Entering text into the input field will update the search result below

SCHH: With Steady Return And High Volatility, This ETF Is Asking For Your Attention


  • SCHH has been providing a steady dividend yield of around 5 percent.
  • SCHH's price multiples suggest investors have faith in the management.
  • SCHH's investors can expect an average price growth between 8 to 10 percent over medium and long term, but the return may be highly volatile.
  • Looking for more investing ideas like this one? Get them exclusively at The Total Pharma Tracker. Learn More »

Scenic view of Lago di Braies in Dolomites

Oleh_Slobodeniuk/E+ via Getty Images

Schwab U.S. REIT ETF (NYSEARCA:SCHH) is an exchange traded fund (ETF) which invests in real estate investment trusts (REITs) from various sectors, such as Residential REITs, Retail REITs, Healthcare REITs, Hotel REITs, Industrial/Office REITs, Specialized REITs, and Diversified REITs. REIT is an entity that owns, operates, and/or finances

About the TPT service

Thanks for reading. At the Total Pharma Tracker, we offer the following:-

Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive curated research material. 

For investors requiring hands-on support, our in-house experts go through our tools and find the best investible stocks, complete with buy/sell strategies and alerts.

Sign up now for our free trial, request access to our tools, and find out, at no cost to you, what we can do for you. 

This article was written by

Avisol Capital Partners profile picture

Avisol Capital Partners is made up of a team of medical experts, finance professionals and techies, all of whom invest their own money in the picks they share. They aim to help readers find the middle ground between value and growth investing, as they demystify the biopharma industry.

They lead the investing group Learn more.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Comments (3)

good article. I bot schh as the schh/spy pair seems to have broken out a multimonth range .. close above 25.51 confirms..significant upside left as on multiyear chart trading near fair value
I don't remember SCHH ever yielding 5%...
Hsiao Ching-Hua profile picture
Thanks for sharing. I owned SCHH for a year, that bring me double digit reward. In this rate-rising environment, I’ll keep SCHH at least for 2-3 years
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.